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   CATEGORIES OF POSTER COMPETITION 
 
1) Clinical /  Nutraceutical /   Pharmaceutical 
2) Molecular Biology / Genetics 
3) Social Sciences / Computer Applications / Others
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SCIENTIFIC CANCER RESEARCH POSTER COMPETITION IN CONJUCTION WITH 
CANCER AWARENESS CARNIVAL UPM 2014 PROGRAMME 
 
 FIRST DAY: 8th  MAY 2014 (THURSDAY) 
8.30 am –3.00 pm Preparation of poster board  by secretariat  
3.00 – 5.00 pm Putting up  of posters 
 
 
 
 
 SECOND DAY: 9th  MAY 2014 (FRIDAY) 
8.00 am –9.00 am Registration of participants  
Putting up of posters 
9.00 am – 11.00 am Judging Session 
11.00 am – 12.00pm Presentation of Certificate of Attendance 
 THIRD DAY: 10th  MAY 2014 (SATURDAY) 
8.00 am –5.00 pm Cancer Awareness Carnival 2014  & Poster Viewing 
8.00 pm – 11.00 pm Prize Giving Ceremony during the Charity Dinner   
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ISOLATION, PURIFICATION AND EVALUATION OF ANTICANCER 
PRINCIPLE FROM ZINGIBER ZERUMBET 
 
Heshu, S.R.1,2,3, Hemn, H.O.1,3*, Abdullah, R.1,2, Chartrand, S.M.4, Zeenathul, N.A.1,2,  Zahra, A.5, 
Mahnaz, H.2, Nozlena, A.S.2  
 
1 Faculty of Veterinary Medicine, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia 
2 Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia 
3 Faculty of Veterinary Medicine, University of Sulaimany, Sulaimany City, Kurdistan Region, Northern Iraq 
4 Director, DigiCare Behavioral Research, Casa Grande, Arizona, USA 
5 Faculty of Science & Technology, University Kebangsaan Malaysia, UKM Bangi, Selangor, Malaysia 
*Corresponding author: himenho75@yahoo.com 
 
The Zingiberaceae family is found in tropical and subtropical areas, with approximately 161 species 
from 18 genera of this family found in Peninsular Malaysia. Zingiber zerumbet (L.) Smith tree 
belonging to this family is an edible ginger, originating in South-East Asia, and has been cultivated 
for thousands of years as a spice and for medical purposes. The aim of this study is to isolate the 
active principle from extracted essential oil of fresh Zingiber Zerumbet rhizomes by steam-
hydrodistillation method. In addition, to determine the purity of this active compound using validated 
reverse phase high performance liquid chromatography (RP-HPLC). Moreover, the antiproliferative 
effects of this active principal on various human cancerous and noncancerous cell lines at 
concentrations of 1 to 100 μg/mL were quantified by MTT assay. As a result, colorless zerumbone 
(ZER) crystals about 1.3 g/kg as an active principal were extracted from the essential oil of fresh Z. 
Zerumbet rhizomes. The purity of ZER crystals were shown to be (99.96%). Simultaneously, ZER 
exhibited significant (P < 0.05) inhibitory effects towards various human cancerous cell lines, while 
not affected noncancerous cell lines. In conclusion, ZER is suggested to be further developed into a 
safe therapeutic compound for the treatment of various human cancers. 
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CARBON NANOMATERIALS AS DRUG TRANSPORTER FOR CANCER 
THERAPY 
 
1,2, *C. A. Che Abdullah and 2R.P.L. Sear. 
 
1Department of Physics, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia 
2Department of Physics and Surrey Materials Institute, University of Surrey, Guildford, Surrey, GU2 7XH, United 
Kingdom 
 
*Corresponding Author: azurahanim@gmail.com 
 
 
There is a vigorous and growing research effort developing carbon nanotubes (CNTs) for medical 
applications. It is now known that nanocomposites of Single Wall Nanotubes (SWNTs) can be used 
to deliver anti-cancer drugs to cells. Also, SWNTs are efficient at converting near infrared (NIR) 
light to heat, and can do so in a cell, and so cancer cells can be targeted for destruction by NIR 
radiation, once the cells have taken up SWNTs. SWNTs are highly insoluble in water, but can be 
functionalized via physical or covalent attachment of solubilizing molecules and drugs of interest. 
Once this is done, they are readily taken up by cells.  We found evidence that our CNT 
nanocomposites were found to enter cells via endocytosis (the mechanism cells use to take up 
nutrients); this agrees with earlier work by Dai and coworkers.  Herein, we perform systematic study 
of the internalization, delivery and subcellular localization and possible adverse effects of SWNTs 
dispersed in culture media and SWNTs wrapped with different fluorescently labelled peptide (FLP-
SWNTs) on Chinese hamster ovary (CHO) cells and SWNTs attached with anti-cancer drug on two 
common cancerous cell lines, human epithelial carcinoma cell line (HeLa) and colorectal cancer cell 
lines (WiDr). 
 
8
Scientific Cancer Research Poster Competition in conjunction with Cancer Awareness Carnival UPM 2014 
 
8 
 
IN VITRO ANTI-CANCER EFFECT OF LAYERED DOUBLE HYDROXIDE-
CHLOROGENIC ACID NANOPARTICLES AS DRUG DELIVERY SYSTEM 
 
Shafinaz  Abd  Gani1,2*,  Farahnaz Barahue4, Mohd. Zobir  Hussein4, Palanisamy  Arulselvan1, 
Sharida  Fakurazi1,3 
 
1Laboratory of Vaccines & Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor,  
2Department of Biochemistry, Faculty of Biotechnology & Biomolecular Sciences, Universiti Putra Malaysia, Serdang, 
Selangor, 
 3Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 
Selangor 
 4Materials Synthesis and Characterisation Laboratory, Institute of Advanced Technology (ITMA) Universiti Putra 
Malaysia,  Serdang, Selangor 
 
*Corresponding Author:shafinaz.abdgani@gmail.com 
 
 
 
Layered double hydroxides (LDHs) have obtained significant attention as nano-sized carriers for 
therapeutic and bio-active molecules. LDH nanoparticles are competent for drug delivery purposes 
due to their numerous advantageous properties such as unique structure, high anionic exchangeability 
and solubility in acidic media which give rise to the controlled release of intercalated molecules. 
Hence, the aim of this study is to investigate the properties of newly constructed drug delivery 
system consisting a natural compound, chlorogenic acid (CA) intercalated into Zn/Al-LDH 
interlayers for the formation of the nanocomposite. Structural and physical properties of chlorogenic 
acid intercalated into Zn/Al-LDH (CA-Zn/Al-LDH) were determined by X-ray diffraction, field 
emission scanning and transmission electron microscope. Loading efficiency of CA in between the 
interlayers of Zn/Al-LDH was investigated using a UV-Vis spectrophotometer. Subsequently for in 
vitro work, the anti-cancer properties of CA-Zn/Al-LDH nanocomposite on various cancer and 
normal cell lines were carried out using 3-(4,5-dimethylthiazol 2-yl)-2,5-diphenyl bromide (MTT) 
reduction assay. Half-maximal inhibitory concentrations of CA-Zn/Al-LDH in all the cell lines was 
found to be ranged from 0-50 μg/L, determined after 24, 48 and 72 h. To justify their efficacy, 
apoptosis induction and clonogenic inhibition of chlorogenic acid-LDH nanocomposite were 
observed and analyzed microscopically. The preliminary result of this study may offer valuable 
primary information towards the development of potential nanodrugs for cancer therapy. 
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PROTOCATECHUIC ACID-ZINC/ALUMINIUM LAYERED DOUBLE 
HYDROXIDE NANOCOMPOSITE AS AN ANTICANCER NANODELIVERY 
SYSTEM 
 
F. Barahuie, 1*, M.Z. Hussein1, Shafinaz Abd Gani2,3, Sharida Fakurazi3,4, Zulkarnain Zainal1 
 
1Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), 
2Department of Biochemistry, Faculty of Biotechnology & Biomolecular Sciences, 
3Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience,UPM 
 4Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra  Malaysia, 43400 UPM, 
Serdang, Selangor, Malaysia. 
 
*Corresponding Author: farahb2424@yahoo.com 
 
Protocatechuic acid, an anticancer agent has been intercalated into Zn/Al-layered double hydroxide 
at Zn to Al molar ratio of 2 using two different preparation methods; co-precipitation and ion-
exchange and labeled as PZAE and PZAC, respectively. The release of the anion, protocatechuate 
from both of the nanocomposites occurred in a controlled manner governed by pseudo-second order 
kinetics. The basal spacing of resulting nanocomposites PZAE and PZAC was 10.2 and 11.0 Å, 
respectively, indicating successful intercalation of protocatechuate anions into the interlayer galleries 
of Zn/Al-LDH in monolayer arrangement with an angle of 24 and 33° from z axis for PZAE and 
PZAC, respectively. The formation of the nanocomposites was confirmed by Fourier transform 
infrared study and surface area analysis showed that the nanocomposites are of mesoporous-type 
material. The thermal stability of the intercalated protocatechuic acid significantly enhanced 
compared to its counterpart, free protocatechuic acid. The drug loading in the nanocomposites was 
estimated to be about 32.6% in PZAE and 29.2% in PZAC. Both PZAE and PZAC nanocomposites 
inhibit the growth of human cervical (HeLa), liver (HepG2) and colorectal (HT29) cancer cell lines 
and show no toxic effect towards normal fibroblast 3T3 cell after 72 hours of treatment. 
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CYTOTOXIC PROFILES OF A NANODRUG DELIVERY BASED ON 6-
MERCAPTOPURINE-COATED MAGNETITE-PEG NANOPARTICLES 
TOWARDS LEUKEMIA (WEHI-3B) CELL LINES 
Dena Dorniani1, Aminu Umar Kura2, Sharida Fakurazi and Mohd Zobir bin Hussein1* 
1Materials Synthesis and Characterization Laboratory (MSCL), Institute of Advanced Technology (ITMA), Universiti 
Putra Malaysia, Selangor, Malaysia. 
2Vaccines and Immunotherapeutics Laboratory, Institute of Bioscience (IBS), Universiti Putra Malaysia, Selangor, 
Malaysia 
 
*Corresponding Author: mzobir@upm.edu.my 
 
 
A drug active, 6-mercaptopurine (MP) was coated on the surface of Fe3O4-PEG nanoparticles using 
co-precipitation method in order to form a new magnetic nanocomposite (FPEGMP). The physico-
chemical properties of the nanocomposite were studied via X-ray diffraction, infrared spectroscopy, 
magnetic measurements, thermal analysis and transmission electron microscopy. The resulting 
superparamagnetic nanocomposite has spherical shape with average particle size diameter of 11 nm. 
Thermal analyses and Fourier transform infrared (FTIR) spectroscopy revealed the formation of 
PEG-MP on the surface of iron oxide nanoparticles and the enhancement of the thermal stability of 
the nanocomposite compared to its counterpart, free 6-mercaptopurine. Release behavior of MP from 
FPEGMP nanocomposite was found to be sustained and governed by pseudo-second order kinetic. 
The maximum percentage release of MP from FPEGMP nanocomposite reached about 60% and 97% 
within approximately 92 and 72 hours when exposed to aqueous solutions at pH 7.4 and pH 4.8, 
respectively. Anti-cancer activity of the nanocomposite shows that the choice of coating material as 
well as the percentage of loading of the active agent could affect the cytotoxic activity of 
nanocomposite towards the mouse myelomonocytic leukemic cell line (WEHI-3B). 
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IN VIVO ASSESSMENT OF NANOSTRUCTURED LIPID CARRIER FOR 
ORAL DELIVERY OF ZERUMBONE IN LEUKEMIC MICE MODEL 
Heshu, S.R.1,2,3*, Abdullah, R.1,2, Hemn, H.O.1,2 , Chartrand, S.M.4, Ahmad Bustamam, A.2,  Zahra, 
A.5, Mahnaz, H.2, Nozlena, A.S.2  
1 Faculty of Veterinary Medicine, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia 
2 Institute of Bioscience, Universiti Putra Malaysia,  UPM Serdang, Selangor, Malaysia 
3 Faculty of Veterinary Medicine, University of Sulaimany, Sulaimany City, Kurdistan Region, Northern Iraq 
4 Director, DigiCare Behavioral Research, Casa Grande, Arizona, USA 
5 Faculty of Science & Technology, University Kebangsaan Malaysia, UKM Bangi, Selangor, Malaysia 
 
*Corresponding Author: heshusr77@gmail.com 
Cancer nanotherapeutics are progressing rapidly with innovative drug delivery systems to 
replace conventional delivery systems. Although, antitumor activity of zerumbone (ZER) 
has been reported, there has been no available information of ZER-loaded nanostructured 
lipid carrier (NLC) affects murine leukemia cells in vivo. In a previous study, ZER was 
incorporated into NLC by high pressure homogenization (HPH) technique. 
Physicochemical characterization included particle size, polydipersity index, zeta potential, 
pH, entrapment efficiency, loading capacity, stability study, and in vitro drug release, as 
well as physicochemical stability after being autoclaved and stored at 4˚C, 25˚C and 40˚C 
for 1 month, were examined. In this study, in vivo effects of ZER-NLC on murine 
leukemia WEHI-3B cells were investigated. The outcomes of histopathology, TEM and 
TUNEL assays of BALB/c leukemia mice revealed that the number of leukemia cells were 
significantly (P < 0.05) decreased in spleen tissue after four weeks of oral administration 
of ZER-NLC. In conclusion, NLC is suggested as a promising carrier for ZER oral 
delivery. 
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ANALYSIS OF PERIPHERAL BLOOD OF OVARIAN CANCER PATIENTS 
INDICATES HIGHER SUB-POPULATIONS OF NATURAL KILLER AND B 
CELLS COMPARED TO HEALTHY VOLUNTEERS 
Tan Jun Hao1,5, Vicknesh a/l Visvalingam2, Noor Azmi bin Mat Adenan4, Norhafizah Mohtaruddin1, 
Maha Abdullah1, Andi Anggeriana1,2,3 
1 Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 
2Hospital Kuala Lumpur 
3Cancer Resource and Education Center (CaRE), Universiti Putra Malaysia 
4University Malaya Medical Centre 
 
       *Corresponding Author:jamestanjh@ymail.com 
Ovarian cancer is a challenging disease to treat, and one of the potential treatments is by 
immunotherapy. NK cells have been shown to play a role in slowing tumour progression and cancer 
development. This study aims to investigate the numbers of NK cells and other lymphocyte sub-
populations in ovarian cancer and their impact on ovarian cancer clinical outcome. This project aims 
to study the significance of different lymphocyte populations, particularly NK cells, involved in the 
peripheral blood of ovarian cancer patients. Venal blood was drawn from ovarian cancer patients 
before chemotherapy. PBMCs were isolated from 13 ovarian cancer patients and 11 age-matched 
healthy volunteers. Immunophenotyping was performed using a commercial kit to quantify the 
lymphocyte populations and RNA isolation performed to examine the expression of KIR genes using 
reverse transcription polymerase chain reaction. Immunophenotyping of PBMC was successfully 
performed on 13 ovarian cancer patients and 11 healthy controls. Significant increases in the mean of 
peripheral NK cells and B cells were found in ovarian cancer patients as compared to the healthy 
controls (P=0.0559). No other significant results were obtained for C D4 and CD8 lymphocytes. 
There was significant increase in numbers of NK cells and B cells in ovarian cancer patients as 
compared to the healthy volunteers. These results should be pursued with a larger sample size with 
the hopes of finding a significant difference between the two groups and to provide a keener insight 
into are promising preliminary results the immune defence against ovarian cancer 
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‘A FLY IN THE OINTMENT’ 
Norafida Bahari, Suzana Abd Hamid 
Department of Imaging, Faculty of Medicine & Health Sciences ,Universiti Putra Malaysia 
*Corresponding Author:norafidab@yahoo.com 
The small endobronchial malignancies are rare entity that can cause obstruction of the major airways, 
causing symptoms such as dyspnoea, cough, haemoptysis and postobstructive pneumonia. The 
obstruction may lead to gradual asphyxiation. Case series of four patients: primary carcinoid, 
mucoepidermoid carcinoma and mixed squamo-adenocarcinoma are reviewed. This paper describes 
each of these cases including the clinical presentation, plain film at presentation, CT abnormalities 
and discusses the utility of CT in their diagnosis. Treatment and progression of disease also will be 
discussed.  
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ANTI CANCER ACTIVITY OF MANGIFERIN FROM METHANOL 
EXTRACT OF FRUIT OF MAHKOTA DEWA (PHALERIA MACROCARPA 
(SCHEFF.) BOERL.) 
 
Adawiah I1*, Luqman Chuah A1, 2, Pin KY3, Dayang Radiah AB1, Umi Kalsom Y4 and Nor Fariza1 
 
1Department of Chemical and Environmental Engineering, Faculty of Engineering, Universiti Putra Malaysia, Malaysia. 
2Institute of Tropical Forestry and Forest Products (INTROP), Universiti Putra Malaysia, Malaysia. 
3Forest Research Institute of Malaysia (FRIM), Malaysia. 
4Department of Biology, Faculty of Science, Universiti Putra Malaysia, Malaysia. 
 
*Corresponding author: adawiah_ismail@yahoo.com 
 
Phaleria macrocarpa (Scheff.) Boerl known as Mahkota Dewa is one of Indonesia's traditional 
medicines from family of Thymelaeaceae. Traditional medicine practitioners claim that the chemical 
compounds in mahkota dewa retains antihistamine, antioxidant and anti cancer effects. In this study, 
one compound has been successfully isolated from methanolic extract of Mahkota Dewa‟s fruit as 
single compound known as mangiferin. To ensure whether this compound; mangiferin contribute to 
the anti cancer activities, the cytotoxic effect on a breast cancer cell line; MCF-7, cervical cancer cell 
line; HeLa, and human colon adenocarcinoma cell; HT-29, was examined. The results show that 
Mahkota Dewa can be promising sources of natural products with potential anti cancer. 
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CYTOTOXICTY OF ZERUMBONE AGAINST LIVER CANCER CELL 
LINES (HepG2) VIA APOPTOSIS ACTIVITY 
 
Nozlena A. Samad1, Ahmad Bustamam Abdul1*, Rasedee Abdullah2, Tengku Azmi Tengku Ibrahim2, 
Heshu Rahman2, Hemn HO2,  S.K. Yeap1 
 
1Institute of Bioscience, University Putra Malaysia, UPM Serdang, Selangor, Malaysia 
2Faculty of Veterinary Medicine, Department of Microbiology and Pathology, University Putra Malaysia,  UPM 
Serdang, Selangor, Malaysia 
 
*Corresponding author: ahmadbstmm@yahoo.com 
 
Zerumbone (ZER), a sesquiterpene phytochemical isolated from a type of edible ginger known as 
"Zingiber Zerumbet Smith" grown in Southeast Asia. The anticancer effects of ZER has been 
previously reported at our Laboratory, which used MTT assay on human cancer cells of several cell 
lines such as cervix (HeLa), leukemia (jurkat) and breast (MCF-7). ZER anti-cancer properties were 
found to be in equivalent with cisplatin, a commercial anticancer drug used preferentially in treating 
cervical cancer in humans. In this study, MTT assay was carried to obtain the IC50 value of 
zerumbone towards HepG2 and normal liver, WRL-68 cell lines.  The cytotoxicity analysis on 
HepG2 cells revealed that the IC50 is 6.20µg/ml. ZER showed no apparent cytotoxicity response 
towards WRL-68 cell lines. Morphological analysis for apoptosis detection by using inverted 
microscope and SEM have produced typical apoptotic characteristic. It showed that zerumbone has 
antiproliferative activity towards liver cancer cell by its ability to induce apoptosis. The outcome of 
this study demonstrates that zerumbone has the ability to increased efficacy with limited toxicity in 
liver cancer treatment. 
 
 
 
 
16
Scientific Cancer Research Poster Competition in conjunction with Cancer Awareness Carnival UPM 2014 
 
16 
 
TOXICITY EFFECT ON DIFFERENT TYPES OF TIGER MILK 
MUSHROOM EXTRACTS AGAINST HUMAN NORMAL LUNG CELL 
(MRC5) AND LUNG CANCER CELL (A549) 
Noraswati Mohd Nor Rashid1*, Nor Azreen Mohd Jamil1, Norasfaliza Rahmad1, Muhamad Syafiq 
Muhamad Rosdi1, Norihan Mohd Saleh1 and Mohd Firdaus Mohamed Ramli2 
1Agro-Biotechnology Institute, Ministry of Science, Technology and Innovation, c/o MARDI Headquarters, 43400, 
Serdang, Selangor 
2University Kuala Lumpur Institute of Medical Science Technology (UniKL MESTECH), A 1-1, Jalan TKS1, Taman 
Kajang Sentral, 43000 Kajang, Selangor. 
 
*Corresponding author: noraswati09@gmail.com 
Lignosus rhinocerus (Cooke) Ryvarden, also known as the “tiger's milk mushroom”, has been 
traditionally utilised for the treatment of cough, fever, chronic hepatitis, gastric ulcer, liver and breast 
cancer based on ethnobotanical knowledge. In this study, cultivated tuber of Tiger‟s Milk Mushroom 
was dried and grinded to obtain the mushroom powder. Five different types of extract were 
performed from this mushroom powder. Those crude extracts were petroleum ether (PE) extract, 
chloroform (CH) extract, methanol (ME) extract, cold water (CW) extract and hot water (HW). The 
aim of this study is to evaluate toxicity effect on these mushroom extracts against human lung cell 
(MRC5) and lung cancer cell (A549) through MTT assay. Results showed that IC50 of PE, CH, ME 
and CW were 53µg/ml, 34µg/ml, 56µg/ml and 37µg/ml on MRC5, respectively. The values showed 
that these four extracts are toxic to MRC5. Only HW extract did not showed 50% inhibition on 
MRC5 but showed toxicity activity on lung cancer cell (A549) at IC50 value of 76 µg/ml. As the 
conclusion, hot water extract of Tiger‟s Milk Mushroom can be suggested as not toxic on human 
lung cell (MRC5) but toxic on lung cancer cell (A549). Fractionation of bioactive compounds from 
hot water extract of Tiger‟s Milk Mushroom will be conducted for further study. 
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CYTOTOXIC EFFECTS OF BIO-SYNTHESIZED ZINC OXIDE 
NANOPARTICLES ON MURINE CELL LINES 
Farideh Namvar1, 2*, Heshu Rahman3,4, Rosfarizan Mohamad1, 5, Susan Azizi6, Parida MD. Tahir1, 
Max Chartrand7, Swee Keong Yeap4 
1  Institute of Tropical Forestry and Forest Products (INTROP), Universiti Putra Malaysia, UPM Serdang, Selangor, 
Malaysia 
2  Animal Development Applied Biology Research Centre, Mashhad  Branch, Islamic Azad University, Mashhad, Iran 
3  Department of Microbiology and Pathology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, UPM Serdang, 
Selangor, Malaysia 
4  Institute of Bioscience (IBS), Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia 
5 Department of Bioprocess Technology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra 
Malaysia, UPM Serdang, Selangor, Malaysia 
6  Department of Chemistry, Faculty of Science, Universiti Putra, Malaysia  UPM Serdang, Selangor, Malaysia 
7  Director, DigiCare Behavioral Research, Casa Grande, Arizona, USA 
 
*Corresponding author:: farideh.namvar@upm.edu.my 
 
Zinc oxide nanoparticles (ZnO-NPs) are among the most appropriate metal oxide nanoparticles to 
exhibit significant potential for treatment properties in a broad spectrum of applications in 
biomedicine, such as in the treatment of various cancers. The aim of this study was to evaluate the in 
vitro cytotoxic activity and cellular effects of previously prepared ZnO-NPs using brown seaweed 
(Sargassum muticum) aqueous extract. Consequently, In vitro anticancer activity was demonstrated 
in murine cancer cell lines of breast cancer (4T1), lung adenocarcinoma (CRL-1451), colon cancer 
(CT-26), and acute myelocytic leukemia (WEHI-3). Treated cancer cells with ZnO-NPs for 72 hours 
demonstrated various levels of cytotoxicity based on calculated IC50 values using MTT assay as 
follows:  21.7 ± 1.3 μg /mL (4T1), 17.45 ± 1.1 μg /mL (CRL-1451), 11.75 ± 0.8 μg /mL (CT-26) and 
5.6 ± 0.55 μg /mL (WEHI-3), respectively. On the other hand, ZnO-NPs treatments for 72 hours 
showed no toxicity against normal mouse fibroblast (3T3) cell lines. Furthermore, distinct 
morphological changes were found by utilizing flourescent dyes, as apoptotic population were 
increased via flowcytometry, while cell cycle block and stimulation of apoptotic proteins were also 
observed. Additionally, the present study showed that the caspase activations contributed to ZnO-
NPs triggered apoptotic death in WEHI-3 cells. Thus, the nature of biosynthesis and the therapeutic 
potential of ZnO-NPs  could prepare the way for further research on the design of green synthesis 
therapeutic agents, particularly in nanomedicine, for the treatment of cancer. 
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Based on data published in April 2011 by WHO about Deaths in worldwide, cancer is the 
third leading cause of death (after heart disease and stroke) in most of developed countries 
and the second leading cause of death (after heart disease) in Malaysia . Therefore, one of the 
challenges for Malaysia and the whole world is carrying out research on cancer in order to 
find its causes and method for therapy and prevention of this disease. Metal nanoparticle 
synthesis using seaweed extract shows rapid and non-toxic process which resulted to nano 
sizes having the greatest potential for biomedical applications. The current study was aimed to 
investigate the anticancer properties of gold nanoparticles synthesized using water extract of 
brown seaweed; Sargassum glaucescens(Au/S.G-NPs). The effect of 3.65±1.69 nm          
Au/S.G-NPs were studied on HeLa (cervical cancer) and 3T3 (mouse fibroblast) using 
tetrazolium dye MTT assay. Later on, in vitro apoptosis effect was evaluated using 
fluorescent microscopy, flow cytometry, and protease caspase activities. After 72 h 
treatment , MTT assay revealed highest and significant cytotoxic effect of Au/S.G-NPs dose 
and time-dependently against cervical cancer cells with IC50 of 4.75 ± 1.23 μg/mL. On the 
other hand, Au/S.G-NPs showed no cytotoxic effect toward mouse fibroblast cells. Moreover, 
Au/S.G-NPs significantly (P < 0.05) arrests HeLa cells at G2/M phase and significantly (P < 
0.05) activated caspases-3 and -9. The results revealed that Au/S.G-NPs can be further 
developed as chemotherapeutic compound for the treatment of cancers especially cervical 
cancer. 
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Prostate cancer has become the second leading cancer among men across ethnic groups in the 
world. Since it is influenced by a complex genetics that may affect the level of susceptibility 
for the development of the disease, four Y-linked short tandem repeats (STRs), DYS388, 
DYS435, DYS437, and DYS439 were genotyped to compare Malaysian prostate cancer 
patients and normal controls males. A total of 175 subjects comprising 84 patients and 91 
healthy individuals from three major ethnics were recruited. Multiplex PCR was optimized to 
co-amplify all four DYS loci. All samples were genotyped for alleles of four DYS loci using 
a Genetic Analysis System. Result showed that allele 10 (A) of DYS388 had a significantly 
lower incidence towards disease than other alleles of this locus, while allele 12 (C) of 
DYS388 and allele 14 (E) of DYS439 showed a significantly higher risk to develop prostate 
cancer compared to other alleles of these loci. Moreover, among 47 different haplotypes 
comprising different alleles of four DYS loci found in the overall study samples, it is noticed 
that AABC and CAAA showed a lower and higher frequency among cases than controls, 
respectively. As a conclusion, Malaysian males who belong to Y-lineages with either allele 
12 of DYS388, allele 14 of DYS439, or haplotype CAAA tend to develop prostate cancer. 
Meanwhile, those belonging to Y-lineages with allele 10 of DYS388 or haplotype AABC are 
more resistant to the disease. Thus, it is suggested that genetic elements give an influence on 
the development of prostate cancer. 
 
 
20
Scientific Cancer Research Poster Competition in conjunction with Cancer Awareness Carnival UPM 2014 
 
 
 20 
MIR-137-MEDIATED LOSS OF KDM5B EXPRESSION LEADS TO 
SUPPRESSION OF THE MALIGNANT PHENOTYPE OF BLADDER 
CANCER CELLS 
Radha Kodiappan1,2, Lai Jiun Yee1, Chan Soon Choy3, Rozita Rosli1,4, Norshariza Nordin5 
Huzlinda Husin6, Fauzah Abd. Ghani6, Rosna Yunus7, Azad Hassan Abdul Razack8, Ong 
Teng Aik8, Abhi Veerakumarasivam1,3,4 
1Medical Genetics Laboratory, Genetics & Regenerative Medicine Research Centre, Faculty of Medicine and 
Health Sciences, Universiti Putra Malaysia, Serdang, Selangor Darul Ehsan. 
2Perdana University Royal College of Surgeons in Ireland, Perdana University, Serdang, Selangor Darul 
Ehsan. 
3Perdana University Graduate School of Medicine, Perdana University, Serdang, Selangor Darul Ehsan. 
4UPM-MAKNA Cancer Research Laboratory, Institute Bioscience, Universiti Putra Malaysia, Serdang, 
Selangor Darul Ehsan. 
5Stem Cell Research  Laboratory, Genetics & Regenerative Medicine Research Centre, Faculty of Medicine and 
Health Sciences, Universiti Putra Malaysia, Serdang, Selangor Darul Ehsan. 
6Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 
Selangor Darul Ehsan. 
7Department of Pathology, Hospital Kuala Lumpur, Jalan Pahang  Kuala Lumpur, Wilayah Persekutuan. 
8Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan. 
 
Corresponding author: abhimanyu@upm.edu.my / drabhi@perdanauniversity.edu.my 
 
The oncogenic role of KDM5B is implicated in the pathogenesis of many cancers including 
bladder cancer (BC). KDM5B is a histone demethylase enzyme that modifies the chromatin 
structure to specify cellular transcriptional states. Overexpression of KDM5B in cancer cells 
is correlated with an increased proliferative capacity. Intriguingly, KDM5B is a cancer/testis 
antigen; while its expression in tumours is ectopically amplified, KDM5B expression in 
normal conditions is limited to embryonic stem cells (ESCs) and the testis in adults. These 
unique characteristics make KDM5B a potential pan-cancer therapeutic target. Thus, this 
study was aimed at identifying potential regulators of KDM5B. Since KDM5B expression in 
ESCs is orchestrated by microRNAs (miRNAs) and the expression of many miRNAs are 
altered in BC, we hypothesized that miRNAs may be the switch that can abate KDM5B 
expression to mitigate the BC malignant phenotype. Based on IHC- and RT-QPCR analysis, 
we found that KDM5B protein and transcript levels were differentially expressed in cancer 
tissues and cell lines, respectively. Amongst several in silico-predicted putative KDM5B-
targeting miRNAs, the in vitro basal expression of miR-137 was inversely correlated with 
KDM5B expression. We demonstrated that the overexpression of miR-137 significantly 
attenuated KDM5B expression, induced G1 cell-cycle arrest, suppressed cell growth and 
blocked invasion and migration of BC cells. In contrast, downregulation of miR-137 
expression led to the reverse effect. By integrating in silico screens of miR-137 putative 
target genes and microarray data using the Ingenuity Pathway Analysis (IPA), we revealed 
that miR-137 possibly exerts control over the cell-cycle through Rb and adenylyl cyclic 
signalling pathways by targeting key regulators of cyclin A. We also showed that miR-137 
gain-of-function increased the expression of tumor suppressor, JDP2. While our results 
suggest that miR-137 can mitigate the KDM5B-associated BC phenotype, further studies on 
understanding the effect on aberrant histone methylation patterns are warranted. 
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Despite significant progress in the development of therapeutic drugs and treatments, deaths 
due to cancer still remains high. These therapies are also not specific to tumour regions, 
hence causing adverse effects to the patients. Bacteria had long been studied for its ability to 
multiple within tumour regions and also reducing tumour volumes. Salmonella had also been 
studied and shown to be able to attack cancerous cells.  To ensure the bacteria therapy is safe 
for clinical trial purposes, the bacteria need to undergo the process of silencing and in vivo 
assessment. This study was carried out to assess the use of SPI knockout S. Typhimurium and 
S. Agona as a possible tumour reduction agent and to investigate the effect of the SPI 
knockout strains on the survival of mice with induced tumour. 3 x 106 CT26 cells suspended 
in PBS were inoculated subcutaneously on the thigh to induce solid tumour. The subjects 
were then treated with the four bacterial treatments via intraperitoneal and intratumoural 
route of administration. The changes in the sizes of the tumours were observed daily using a 
calipher. The subjects were then sacrificed and the organs were harvested for 
histopathological analysis. One-way ANOVA indicated that the treatments had significant 
effects at p < 0.05, on both the changes of the tumour volumes and also the survival periods 
of the subjects. Subjects treated with S. Agona showed better survival compared to subjects 
treated with S. Typhimurium. S. Agona is found to be a better candidate as a tumour 
reduction agent, compared to S. Typhimurium, since it showed longer survival period of 
subjects after treatment and yet, had similar capacity as a tumour reduction agent. 
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Dogs develop neoplasia naturally and spontaneously just like in humans. Mammary gland 
tumour is the most common neoplasm in female dogs. Age of dog, neuter status, breed size 
and pedigree have all been described to significantly affect the risk of canine mammary gland 
tumour (CMT) development. This study aimed to determine the prevalence of CMT 
diagnosed at the Veterinary Histopathology Laboratory, Faculty of Veterinary Medicine, 
University Putra Malaysia, between 2006 and 2012 and to evaluate the proportion of breed 
types, neuter status and age on the odds of CMT development. Forty-eight cases with 
confirmed diagnosis of CMT on histopathology were reviewed retrospectively. Thirty-nine 
(81.25%) were diagnosed as adenocarcinoma and 8.33% (n=4) for each squamous cell 
carcinoma and mixed cell tumour respectively. Adenoma was only diagnosed in one CMT. 
The prevalence of CMT in this study is 39%. When CMT cases were compared with all other 
diagnosis in dogs, CMT was significantly more in adult dogs (p=0.032, logistic regression 
0.012) and intact dogs (p=0.009, logistic regression, (0.003). When CMT cases were 
compared with other types of neoplasia, significant association with CMT was observed in 
pure breeds (p=0.025) and intact dogs (p=0.000034, logistic regression 0.00042). This study 
found that pure breed dogs, intact dogs and older dogs (>5years) have higher odds of having 
CMT. 
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Urothelial cell carcinoma (UCC) is the most common form of bladder cancer and is 
associated with the need for life-long surveillance once a patient is diagnosed with a non-
invasive disease. Due to the long-term risk of recurrence and the need for life-long routine 
monitoring and therapy, the cost per UCC patient from diagnosis to death is the highest of all 
cancers. The development of non-invasive biomarkers of recurrence and progression can 
increase survival, decrease treatment costs and improve patient quality of life. However, to 
date, no biomarker(s) have been endorsed for the use in the clinical management of UCC, 
especially in predicting risk of progression and recurrence. CTAG1B was previously found to 
be highly expressed in high-stage and grade bladder cancer, albeit in Caucasian cohorts. 
However, despite its potential as a target for cancer immunotherapy, the effect of expression 
modulation on cellular phenotypes has never been reported. In this study, we overexpressed 
CTAG1B in an invasive bladder cancer cell line, EJ28 after we confirmed that this cell line 
minimally expressed CTAG1B. The cells were transfected with CTAG1B-pcDNA3.1(-) and 
the level of expression was confirmed by qRT-PCR. Once the expression was confirmed to 
persist up to 72h post-transfection, the transfected cells were subjected to various phenotypic 
assays. In addition, the pattern of CTAG1B expression in a cohort of Malaysian bladder 
cancer paraffin-embedded tissues was also determined using immunohistochemistry. The 
effect of CTAG1B overexpression on the cell cycle, migratory and proliferative potential was 
observed. The changes in phenotype were compared with that of untransfected and mock 
controls. CTAG1B was overexpressed 20 times as compared to the untransfected and mock 
controls in the transfected cells. CTAG1B overexpression resulted in cells to migrate slower 
at 24h post-transfection but proliferate significantly faster after 72-96h post-transfection. In 
addition, CTAG1B was more frequently expressed in advanced bladder cancer stages and 
grades. The findings from this study contribute to the current knowledge of CTAG1B‟s role 
in tumourigenesis. Further functional studies will contribute towards realising the potential of 
CTAG1B as a biomarker for predicting the risk of progression and recurrence of bladder 
cancer. 24
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Mammary gland tumour (CMT) is the most common neoplasm which occurs naturally in 
dogs. CMT affects mainly female dogs and can lead to metastatic disease and eventually 
death if untreated. Among the recent biomarkers involved in growth signaling explored in 
human cancers which are yet to be explored in canine mammary gland tumours are the 
fibroblast growth factor receptors. This study aimed to determine the expression of FGFRs in 
CMT and the relationship between the expression and clinicopathological parameters. Forty-
six CMT were immunohistochemically probed for the expression of FGFR2, FGFR3 and 
FGFR4 using rabbit polyclonal antibodies. Western blotting was used to evaluate cross 
reactivity of the antibodies with the canine FGFR protein. The expression of FGFR2 was 
significantly associated with histopathology grade 3 of the tumours p=0.027. FGFR4 
expression was associated with large breed dogs p=0.044, and large tumour size (>3cm), 
p=0.045. Many studies in human cancers have reported prognostic value of FGFR 
expression. FGFR2 expression was associated with histopathology grade, indicating the 
usefulness of high FGFR2 expression in CMT as an indicator of increased tumour 
malignancy. Large tumours have shown significantly higher FGFR4 expression. Tumour size 
is one of the criteria for tumour staging (TNM), which placed large tumours (>3cm) on stages 
2 and above. Large breed dogs have a significantly higher FGFR4 expression in this study. 
Based on these findings, FGFR2 and 4 can be used as markers for advanced and aggressive 
CMT which further studies are warranted to evaluate for possible targeted therapy.   
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The expanding roles of the immune system in tumourigenesis have established 
immunotherapy as a potential mainstream cancer therapeutic modality. Ex vivo expanded and 
activated cytotoxic T-lymphocytes (CTLs) and natural killer (NK) cells have been found to 
be efficacious in the treatment of various types of cancers. One of the biggest limitations is 
the ability to generate and store cytotoxic immune cells in larger numbers without losing its 
cytotoxicity. Consequently, we evaluated the in vitro cytotoxic activity of freshly cultured 
and cryopreserved CTLs and NK cells that were expanded in vitro. We also compared the 
synergistic cytotoxic activity of CTLs and NK cells in combination. The cytotoxic activity 
was measured in bladder cancer cell lines, EJ28 (invasive) and RT112 (minimally-invasive). 
All experiments were run in three replicates. The cellular phenotype of the isolated and 
expanded effector cells was characterised using flow cytometry. MTT assay was performed 
to assess the dose- and time-dependent cell-mediated cytotoxic activity in the bladder cancer 
cells. An effector to target ratio of 1:1, 2:1, 5:1, 10:1 and 20:1 was tested after 4 h, 12 h and 
24 h incubation. The fresh in vitro expanded effector cells had a high percentage of cell 
viability and expressed cytotoxic markers CD8+ and CD56+ in the CTL and NK cell 
cultures, respectively. Although the expansion capacity of the cryopreserved cells was 
limited, the expression of the functional markers and cytotoxic activity of these effector cells 
were maintained. All the effector cells exhibited significant cytotoxic activity at the effector 
to target ratio of 5:1 at 4 hours of co-culture. This was confirmed through the real-time 
observation of the morphological changes of the cells using an inverted phase contrast and 
time-lapse confocal microscope. The ex vivo generated CTLs and NK cells appear to retain 
their functionality, especially in recognizing their allogeneic target and thus, serve as a 
foundation to build on for future therapeutic applications.                                             . 
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A cancer diagnosis brings with it multiple psychological crises, including loss of control, loss 
of self-efficacy, isolation, decrease self-esteem and, grief. Several studies have presented 
evidences that actual or stimulated view of nature can produce substantial restoration from 
psychological stress within a few minutes. A research also found that patients recovered 
faster and with fewer strong medications when windows faced a natural view rather than a 
brick wall.  This paper will discuss how outdoor spaces with restorative qualities may provide 
an environment conducive to stress reduction, mental repose, emotional recovery and, the 
enhancement of mental and physical energy. Literature concerning the design 
recommendations for outdoor environments for cancer patients are identified and analysed. 
Among the design considerations include implementing interactive garden features, spaces 
for different type of users (adult, children, staff and visitors) and, easy access. A case study 
using Post Occupancy Evaluation at the National Cancer Institute in Malaysia is being carried 
out in order to investigate the possibilities of having a restorative outdoor environment in a 
local context. The knowledge gathered from this study may contribute to the body of 
knowledge in designing outdoor environments for cancer treatment centres in Malaysia. 
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Ovarian cancer is the fifth common cancer among Malaysian women from all ethnicities. 
Ovarian cancer is not easy to detect early. Often women with ovarian cancer have no 
symptoms or show mild and non-specific symptoms, until the disease has reached an 
advanced stage. Researchers are exploring ways to improve the early detection of ovarian 
cancer. This includes exploring the usefulness of a trans-vaginal ultrasound, and of measuring 
levels of CA-125, a tumor marker that is often found in higher than normal amounts in the 
blood of women with ovarian cancer. In an effort to improve the quality of healthcare 
delivery to cancer patients, O-CareCloud for patient management system on cloud is 
providing the online availability of ovarian cancer patient‟s health record, to retrieve and 
storage data and management. This system is for department O&G of Hospital Serdang 
focusing on ovarian patient.  The scope of our system focus on helping the doctors to access 
and diagnose the tumour from an ultrasound examination which the doctors can differentiate 
a fluid filled cyst, solid tumour masses and healthy tissues. Second the system identify by 
using the result of CA-125 Assay blood test which is to measure the level of CA-125, a 
tumour marker, in the blood. The system can be accessed by doctors in charged portably 
meaning anywhere and anytime.  
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The leading cancer diagnosed in woman in Malaysia and Asia Pacific region is the breast cancer. 
With the introduction of standardized image interpretation criterion and the increase in 
computational capacity coupled with the renewed interest from the medical community, breast 
thermography is now being considered as an adjacent to the mammography. The lack of any 
ionizing radiation makes thermography an ideal method for initial screening of young women, 
also the chemotherapy progress can be easily monitored by thermography while other methods 
such as mammography cannot be used due to the caused radiation. Despite the fact that computer 
aided detection/diagnosis (CAD) of breast thermography has become highly accurate, Image 
segmentation methods for breast thermography remained at a moderately accuracy, while the 
basis for any good CAD system is a proper segmentation. To address this issue a new framework 
based on random walkers were developed to segment breasts in thermography images. In breast 
thermography diagnostic, proper detection and segmentation of the breast boundaries present the 
biggest challenge. As the boundaries of breasts, especially in the upper quadrants, are usually not 
present, this produces a great deal of challenge to segment breasts automatically. Many 
approaches have been developed to segment the breast in thermography such as Snakes, Active 
Contours and Circular Hough Transforms, but most of these methods fail to detect the 
boundaries of the breast with the required level of accuracy especially the upper boundaries of 
the breast, while most of them require the image to be manually adjusted and cropped to ensure 
proper segmentation. By utilizing random walkers, the breast can be segmented accurately and 
automatically which in turn will increase the accuracy and the reliability of human interpretation 
and/or computer aided detection/diagnosis systems. 
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Breast cancer is the leading cancer killer among women. Early detection and new treatments 
have improved survival rates. Although mammography is the gold standard for breast cancer 
screening, increasing awareness indicate that there is some limitation for part of women whom 
mammography reduce sensitivity based on their breast density. Other modalities such as 
ultrasound and magnetic resonance imaging and recently computed tomography laser 
mammography (CTLM) are often suggested as an adjunct to mammography to achieve 
additional information and increase sensitivity. The angiogenesis is known a critical for tumor 
growth and spread of breast cancers. Computed tomography laser mammography (CTLM) 
CTLM has been introduced to verify angiogenesis at early stage. In this modality, there are no 
restriction factors such as age or breast density. Main difficulty for radiologists is closeness of 
color shade to interpret CTLM images. Computer-aided detection /diagnosis (CAD) systems 
have been developed to help radiologists in order to increase diagnosis accuracy. Generally, a 
CAD system consists of four stages: (a) pre-processing, (b) segmentation of regions of interest, 
(c) feature extraction and selection, and finally (d) classification. The aim of this research is to 
develop a CAD system in computed tomography laser mammography (CTLM) to detect and 
classify benign and malignant lesions in the breast.                                                       .  
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The advent of integrative approach has shifted cancer classification task from purely data-centric to 
incorporate prior biological knowledge. Integrative analysis of gene expression data with multiple 
biological sources is viewed as a promising approach to classify and to reveal relevant cancer-specific 
biomarker genes. The identification of biomarker genes can be used as a powerful tool for understanding 
the complex biological mechanisms, and also for diagnosing and treatment of cancer diseases. However, 
most integrative-based classifiers only incorporate a single type of biological knowledge with gene 
expression data within the same analysis.  For instance, gene expression data is normally integrated with 
functional ontology, metabolic pathways, or protein-protein interaction networks, where they are then 
analysed separately and not simultaneously. Apart from that, current methods generates a large number of 
candidate genes, which still require further experiments and testing to identify the potential biomarker 
genes. Hence, this study aims to resolve the problems by proposing a systematic integrative framework for 
cancer gene expression analysis to the classification task. The association based framework is capable to 
integrate and analyse multiple prior biological sources simultaneously. Set of biomarker genes that are 
relevant to the cancer diseases of interest are identified in order to improve classification performance and 
its interpretability. In this paper, the proposed approach is tested on a breast cancer microarray dataset and 
integrated with protein interaction and metabolic pathway data. The results shows that the classification 
accuracy improved if both protein and pathways information are integrated into the microarray data 
analysis.  
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